Global Industry Growth Driving Factors:
The global apheresis market is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.
However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.
Research Methodologies Followed for This Study:
In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing apheresis, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include hospitals, blood collection centers, transfusion clinics, and healthcare payers.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the apheresis market.
It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Download PDF Brochure@
# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.
# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.
# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.
# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.
In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market
Based on end users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2018, the blood collection centers and blood component providers segment accounted for the largest share of 67.5% of the global apheresis market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness of blood collection.
Critical Questions Answered:
# Where will these developments take the industry in the mid-to-long term?
# Who are the major end users in the apheresis market, and what are the benefits they avail by implementing apheresis technology?
# What are the recent trends in the apheresis market?
# What are the major market dynamics and their impact on overall market growth?
# What is the global scenario of the apheresis market?
North America accounted for the largest share of the apheresis market in 2018
The apheresis market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the apheresis market. The large share of this region can be attributed to easier access to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.
Request Sample Pages@